Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03802240 |
|---|---|
| Brief Title: | Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure |
| First Submitted : | January 7, 2019 |
| First Submitted that Met QC Criteria : | January 10, 2019 |
| First Posted : | January 14, 2019 |
| Last Update Submitted that Met QC Criteria : | November 23, 2023 |
| Last Update Posted : | November 27, 2023 |